NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Help Therapeutics

Help Therapeutics

Private
NanjingHealthcare & Life Scienceshttps://helptherapeutics.com/

Last Round

Series C

Nov 15, 2021

Total Funding Raised

$35.51M

Company Overview

Help Therapeutics is a biotechnology company that develops induced-pluripotent stem cell (iPSC) and mesenchymal stem cell (MSC) technology to treat degenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Infrastructure

Keywords

cell therapyiPSCinduced pluripotent stem cellregenerative medicineautomated cell manufacturingbiomanufacturingoff-the-shelf therapyallogeneic cell therapybiotech lab automationstem cell bankcardiomyocyte injectionbiorepositoryclinical-stage biopharmalab-grown tissueai in biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Help Therapeutics Comparables

Compare Help Therapeutics with similar companies based on industry and business-model similarity.

Help Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Heartseed
89%
Bayer AG
82%
iHeart Japan Corporation
79%

Help Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CNov 15, 2021
Series A ExtensionOct 15, 2020
Series AJun 1, 2016

Key People

Founding team and executive leadership

Zhaomin Li

Chief Operating Officer Of USA Branch

Executive Team

Help Therapeutics Investors

Notable investors and investment history

Help Therapeutics investors
InvestorRounds
Oriental Fortune CapitalSeries A, Angel
Legend StarSeries A Extension, Series A, Angel
Ming BioventuresSeries C
Jinmao CapitalSeries C
Share CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2026

    Headcount grew 24% QoQ (from 21 to 26 employees)

  • Jun 16, 2025

    Co-developing advanced heart failure treatment HiCM-188 with China Resources Sanjiu.

Help Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Help Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Help Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNanjing
Employee Range26
Year Founded2016
Last FundingNov 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.